Reported 3 months ago
Humana's (HUM) stock has taken a significant hit due to recent alterations in the US government's Medicare quality ratings, which are expected to adversely affect the company's profits. Only 45% of its plans now receive ratings of 4 stars or higher, a steep decline from 94%, leading to concerns about the impact on their member base.
Source: YAHOO